REDHILL BIOPHARMA LTD. Nonderivative Financial Liabilities Undiscounted Cash Flows
REDHILL BIOPHARMA LTD. (RDHL) had Nonderivative Financial Liabilities Undiscounted Cash Flows of $12.91 million as of 2024-12-31, per its 20-F filed 2025-04-10.
Financial Statements › Notes
ifrs-full:NonderivativeFinancialLiabilitiesUndiscountedCashFlows · last filed 2025-04-10
- 2024-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows $12.91M.
- 2023-12-31: Nonderivative Financial Liabilities Undiscounted Cash Flows $10.95M.
| Period end | Nonderivative Financial Liabilities Undiscounted Cash Flows |
|---|---|
| 2024-12-31 | $12.91M 20-F · filed 2025-04-10 |
| 2023-12-31 | $10.95M 20-F · filed 2025-04-10 |